X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

4.040

-0.270 (-6.26%)

At close: Mar 27, 2026, 4:00 PM EDT

4.000

-0.040 (-0.99%)

After-hours: Mar 27, 2026, 4:37 PM EDT

X4 Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	367	364	125	140	121	64
Market Cap Growth	580.28%	189.93%	-10.69%	16.23%	87.57%	-38.56%
Enterprise Value	191.6	186.92	100.19	83.39	35	20.54
Last Close Price	4.04	4.00	22.01	25.16	29.79	68.70
PE Ratio	-	-2.14	-3.94	-1.47	-0.65	-0.57
PS Ratio	10.46	10.36	49.05	-	-	-
PB Ratio	1.97	1.95	5.66	2.75	1.63	1.00
P/TBV Ratio	0.92	0.91	6.66	2.92	0.85	0.92
P/FCF Ratio	-	-4.25	-0.96	-1.45	-1.56	-0.90
P/OCF Ratio	-	-4.25	-0.96	-1.45	-1.57	-0.91
EV/Sales Ratio	5.46	5.32	39.18	-	-	-
EV/EBITDA Ratio	-	-2.18	-0.41	-0.78	-0.40	-0.24
EV/EBIT Ratio	-	-2.15	-0.41	-0.78	-0.40	-0.24
EV/FCF Ratio	-	-2.18	-0.76	-0.86	-0.45	-0.29
Debt / Equity Ratio	0.41	0.41	3.47	1.12	0.49	0.59
Debt / EBITDA Ratio	-0.90	-0.90	-0.32	-0.54	-0.44	-0.47
Debt / FCF Ratio	-0.87	-0.90	-0.59	-0.60	-0.50	-0.56
Net Debt / Equity Ratio	-0.94	-0.94	-1.08	-1.09	-1.13	-0.65
Net Debt / EBITDA Ratio	2.05	2.05	0.10	0.52	0.95	0.50
Net Debt / FCF Ratio	1.98	2.05	0.18	0.58	1.08	0.59
Asset Turnover	0.16	0.16	0.02	0	0	0
Inventory Turnover	1.58	1.58	0.57	-	-	-
Quick Ratio	9.84	9.84	3.16	5.02	5.50	5.89
Current Ratio	10.16	10.16	3.41	5.34	5.76	6.27
Return on Equity (ROE)	-75.99%	-75.99%	-102.26%	-161.83%	-135.70%	-129.30%
Return on Assets (ROA)	-39.79%	-39.79%	-169.19%	-71.06%	-64.97%	-70.92%
Return on Invested Capital (ROIC)	-670.61%	-670.61%	-2067.04%	-849.42%	-475.23%	-302.73%
Return on Capital Employed (ROCE)	-45.94%	-45.94%	-207.09%	-83.46%	-74.94%	-79.51%
Earnings Yield	-21.56%	-46.75%	-25.40%	-67.85%	-153.07%	-174.24%
FCF Yield	-23.31%	-23.55%	-104.63%	-68.77%	-63.90%	-111.03%
Buyback Yield / Dilution	-531.04%	-531.04%	-13.08%	-179.91%	-146.71%	-28.25%
Total Shareholder Return	-531.04%	-531.04%	-13.08%	-179.91%	-146.71%	-28.25%

Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q